Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1983 1
1984 1
1985 2
1986 3
1987 6
1988 10
1989 9
1990 12
1991 13
1992 21
1993 20
1994 23
1995 22
1996 16
1997 21
1998 26
1999 16
2000 29
2001 23
2002 54
2003 67
2004 62
2005 91
2006 81
2007 95
2008 106
2009 124
2010 147
2011 168
2012 229
2013 293
2014 309
2015 348
2016 357
2017 405
2018 461
2019 526
2020 573
2021 690
2022 823
2023 726
2024 622
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

6,845 results

Results by year

Filters applied: . Clear all
Page 1
Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients.
Zhou Z, Ding Z, Yuan J, Shen S, Jian H, Tan Q, Yang Y, Chen Z, Luo Q, Cheng X, Yu Y, Niu X, Qian L, Chen X, Gu L, Liu R, Ma S, Huang J, Chen T, Li Z, Ji W, Song L, Shen L, Jiang L, Yu Z, Zhang C, Tai Z, Wang C, Chen R, Carbone DP, Xia X, Lu S. Zhou Z, et al. Among authors: gu l. J Hematol Oncol. 2022 May 18;15(1):62. doi: 10.1186/s13045-022-01283-7. J Hematol Oncol. 2022. PMID: 35585646 Free PMC article.
Peripheral Organ Injury After Stroke.
Wang J, Zhang J, Ye Y, Xu Q, Li Y, Feng S, Xiong X, Jian Z, Gu L. Wang J, et al. Among authors: gu l. Front Immunol. 2022 Jun 1;13:901209. doi: 10.3389/fimmu.2022.901209. eCollection 2022. Front Immunol. 2022. PMID: 35720359 Free PMC article. Review.
Monocyte chemoattractant protein-1.
Gu L, Tseng SC, Rollins BJ. Gu L, et al. Chem Immunol. 1999;72:7-29. doi: 10.1159/000058723. Chem Immunol. 1999. PMID: 10550927 Review. No abstract available.
Anticancer nanomedicines harnessing tumor microenvironmental components.
Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Li Y, et al. Among authors: gu l. Expert Opin Drug Deliv. 2022 Apr;19(4):337-354. doi: 10.1080/17425247.2022.2050211. Epub 2022 Mar 14. Expert Opin Drug Deliv. 2022. PMID: 35244503 Review.
Nanotechnology in Drug Delivery for Liver Fibrosis.
Gu L, Zhang F, Wu J, Zhuge Y. Gu L, et al. Front Mol Biosci. 2022 Jan 11;8:804396. doi: 10.3389/fmolb.2021.804396. eCollection 2021. Front Mol Biosci. 2022. PMID: 35087870 Free PMC article. Review.
Prostacyclins and pulmonary arterial hypertension in children.
Wu Y, Liu HM, Gu L, Li QW, Zhu L. Wu Y, et al. Among authors: gu l. Eur Rev Med Pharmacol Sci. 2022 Jan;26(1):37-45. doi: 10.26355/eurrev_202201_27745. Eur Rev Med Pharmacol Sci. 2022. PMID: 35049017 Free article. Review.
PmiRtarbase: A positive miRNA-target regulations database.
Xu P, Li X, Liang Y, Bao Z, Zhang F, Gu L, Kosari S, Liu W. Xu P, et al. Among authors: gu l. Comput Biol Chem. 2022 Jun;98:107690. doi: 10.1016/j.compbiolchem.2022.107690. Epub 2022 Apr 29. Comput Biol Chem. 2022. PMID: 35567946
6,845 results